227 related articles for article (PubMed ID: 27344013)
21. Ubiquitination and degradation of the thrombopoietin receptor c-Mpl.
Saur SJ; Sangkhae V; Geddis AE; Kaushansky K; Hitchcock IS
Blood; 2010 Feb; 115(6):1254-63. PubMed ID: 19880496
[TBL] [Abstract][Full Text] [Related]
22. Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics.
Li J; Xia Y; Kuter DJ
Br J Haematol; 1999 Aug; 106(2):345-56. PubMed ID: 10460590
[TBL] [Abstract][Full Text] [Related]
23. Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia.
Shin J; Kim MJ; Quan X; Kim JW; Lee S; Park S; Jeong JY; Yea K
BMC Cancer; 2023 May; 23(1):490. PubMed ID: 37259024
[TBL] [Abstract][Full Text] [Related]
24. Humanized VB22B minibody for human Mpl stimulates human megakaryopoiesis but does not enhance platelet aggregation.
Matsuki E; Miyakawa Y; Yamane A; Okamoto S
Exp Hematol; 2011 Aug; 39(8):829-36. PubMed ID: 21605620
[TBL] [Abstract][Full Text] [Related]
25. Thrombopoietin and the c-Mpl receptor: insights from gene targeting.
Alexander WS
Int J Biochem Cell Biol; 1999 Oct; 31(10):1027-35. PubMed ID: 10582337
[TBL] [Abstract][Full Text] [Related]
26. The residual megakaryocyte and platelet production in c-mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor.
Gainsford T; Nandurkar H; Metcalf D; Robb L; Begley CG; Alexander WS
Blood; 2000 Jan; 95(2):528-34. PubMed ID: 10627458
[TBL] [Abstract][Full Text] [Related]
27. C-Cbl regulates c-MPL receptor trafficking and its internalization.
Märklin M; Tandler C; Kopp HG; Hoehn KL; Quintanilla-Martinez L; Borst O; Müller MR; Saur SJ
J Cell Mol Med; 2020 Nov; 24(21):12491-12503. PubMed ID: 32954656
[TBL] [Abstract][Full Text] [Related]
28. Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia.
Horikawa Y; Matsumura I; Hashimoto K; Shiraga M; Kosugi S; Tadokoro S; Kato T; Miyazaki H; Tomiyama Y; Kurata Y; Matsuzawa Y; Kanakura Y
Blood; 1997 Nov; 90(10):4031-8. PubMed ID: 9354672
[TBL] [Abstract][Full Text] [Related]
29. Cytokine production and function in c-mpl-deficient mice: no physiologic role for interleukin-3 in residual megakaryocyte and platelet production.
Gainsford T; Roberts AW; Kimura S; Metcalf D; Dranoff G; Mulligan RC; Begley CG; Robb L; Alexander WS
Blood; 1998 Apr; 91(8):2745-52. PubMed ID: 9531584
[TBL] [Abstract][Full Text] [Related]
30. Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit.
Broudy VC; Lin NL; Fox N; Taga T; Saito M; Kaushansky K
Blood; 1996 Sep; 88(6):2026-32. PubMed ID: 8822921
[TBL] [Abstract][Full Text] [Related]
31. c-mpl, the thrombopoietin receptor.
Vainchenker W; Methia N; Debili N; Titeux M; Wendling F
Thromb Haemost; 1995 Jul; 74(1):526-8. PubMed ID: 8578519
[TBL] [Abstract][Full Text] [Related]
32. [Megakaryopoiesis: regulation of platelet production by thrombopoietin].
Vainchenker W; Besancenot R; Favale F
Bull Acad Natl Med; 2013 Feb; 197(2):395-406. PubMed ID: 24919369
[TBL] [Abstract][Full Text] [Related]
33. Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation.
Goncalves F; Lacout C; Villeval JL; Wendling F; Vainchenker W; Dumenil D
Blood; 1997 May; 89(10):3544-53. PubMed ID: 9160659
[TBL] [Abstract][Full Text] [Related]
34. Regulation of hematopoietic stem cells by their mature progeny.
de Graaf CA; Kauppi M; Baldwin T; Hyland CD; Metcalf D; Willson TA; Carpinelli MR; Smyth GK; Alexander WS; Hilton DJ
Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21689-94. PubMed ID: 21115812
[TBL] [Abstract][Full Text] [Related]
35. Functional characterization of c-Mpl ectodomain mutations that underlie congenital amegakaryocytic thrombocytopenia.
Varghese LN; Zhang JG; Young SN; Willson TA; Alexander WS; Nicola NA; Babon JJ; Murphy JM
Growth Factors; 2014 Feb; 32(1):18-26. PubMed ID: 24438083
[TBL] [Abstract][Full Text] [Related]
36. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.
Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D
Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212
[TBL] [Abstract][Full Text] [Related]
37. Thrombocytopenic c-mpl(-/-) mice can produce a normal level of platelets after administration of 5-fluorouracil: the effect of age on the response.
Levin J; Cocault L; Demerens C; Challier C; Pauchard M; Caen J; Souyri M
Blood; 2001 Aug; 98(4):1019-27. PubMed ID: 11493447
[TBL] [Abstract][Full Text] [Related]
38. Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets.
Fielder PJ; Gurney AL; Stefanich E; Marian M; Moore MW; Carver-Moore K; de Sauvage FJ
Blood; 1996 Mar; 87(6):2154-61. PubMed ID: 8630374
[TBL] [Abstract][Full Text] [Related]
39. Targeting a thrombopoietin-independent strategy in the discovery of a novel inducer of megakaryocytopoiesis, DMAG, for the treatment of thrombocytopenia.
Wang L; Liu S; Luo J; Mo Q; Ran M; Zhang T; Li X; Zou W; Mei Q; Chen J; Yang J; Zeng J; Huang F; Wu A; Zhang C; Wu J
Haematologica; 2023 May; 108(5):1394-1411. PubMed ID: 36546424
[TBL] [Abstract][Full Text] [Related]
40. Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice.
Carver-Moore K; Broxmeyer HE; Luoh SM; Cooper S; Peng J; Burstein SA; Moore MW; de Sauvage FJ
Blood; 1996 Aug; 88(3):803-8. PubMed ID: 8704234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]